Ruxolitinib

Papers on ruxolitinib

36 papers2 new in 30 days

Thursday, October 29

Monday, October 26

Journal of Translational Medicine

Ruxolitinib reduces retinal blood vessel leakage in rats

In Brown-Norway rats with laser-induced eye damage, the drug reduced abnormal blood vessel area and accelerated the recovery of retinal function.In Brown-Norway rats with laser-induced eye damage, the drug reduced abnormal blood vessel area and accelerated the recovery of retinal function.

The SASP is associated with JAK1/2-STAT3 signaling in senescent ARPE-19 cells.
Rat studyEye

Thursday, October 8

Friday, October 2

Friday, August 28

Neurotherapeutics

Enzyme-blocking drugs linked to lower Parkinson disease risk

Among 11 drugs examined, sorafenib prescription fills were linked to a relative risk of 0.43 for Parkinson disease compared with no fills for that drug.Among 11 drugs examined, sorafenib prescription fills were linked to a relative risk of 0.43 for Parkinson disease compared with no fills for that drug.

Case-control studyParkinson's disease

Friday, August 21

Saturday, August 8

Saturday, July 25

Thursday, June 18

Thursday, June 4

Research Square

Delayed drug delivery improved bone repair in aged mice

In an experiment with six aged female mice per group, grafts that delayed ruxolitinib release produced more new bone after nine weeks.In an experiment with six aged female mice per group, grafts that delayed ruxolitinib release produced more new bone after nine weeks.

Preprint: mouse studyBones and joints

Saturday, May 30

Friday, March 27

Monday, March 23

Wednesday, March 18

Thursday, February 26

Friday, February 6

Sunday, January 18

Tuesday, December 30

Saturday, November 1

Friday, September 5

Tuesday, April 29

Thursday, March 6

Friday, December 27

Monday, September 9

Saturday, August 10

Monday, July 8

Friday, November 17

Tuesday, September 5

Thursday, June 2

Thursday, December 16